StockData
PAHCNasdaqPharmaceutical PreparationsFiscal year ends June 30

PHIBRO ANIMAL HEALTH CORP

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 26, 2026
$39.34+0.52 (+1.34%)

Close on Oct 19, 2026

Market cap
$1.61B
P/E (TTM)
16.2
Dividend yield
1.22%

Phibro Animal Health statistics

Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison

Valuation

MeasurePhibro Animal HealthIndustry median
Market Cap$1.60B$164.85M
Enterprise Value$1.52B$87.06M
PE Ratio16.1919.63
PS Ratio1.053.60
PB Ratio4.142.03
P/TBV Ratio5.412.31
P/FCF Ratio161.9017.44
P/OCF Ratio23.1613.32

Enterprise value

MeasurePhibro Animal HealthIndustry median
EV / Sales1.002.43
EV / EBITDA6.1614.69
EV / EBIT7.7918.47
EV / FCF153.5920.97

Income (trailing twelve months)

MeasurePhibro Animal HealthIndustry median
Revenue$1.52B$57.94M
Gross Profit$512.52M$90.47M
Operating Income$194.40M-$21.44M
Pretax Income$137.35M-$14.45M
Net Income$99.72M-$22.46M
EBITDA$245.91M-$16.91M
EPS (Diluted)$2.43-$0.83

Margins

MeasurePhibro Animal HealthIndustry median
Gross Margin33.8%52.3%
Operating Margin12.8%-44.5%
Pretax Margin9.05%-13.0%
Profit Margin6.57%-39.2%
EBITDA Margin16.2%-31.3%
FCF Margin0.65%-8.85%

Returns

MeasurePhibro Animal HealthIndustry median
Return on Equity (ROE)29.7%-53.1%
Return on Assets (ROA)6.97%-41.0%
Return on Invested Capital (ROIC)24.7%-32.0%
Return on Capital Employed (ROCE)16.4%-37.8%

Growth

MeasurePhibro Animal HealthIndustry median
Revenue Growth (YoY)17.1%6.01%
Net Income Growth (YoY)106.6%-37.7%
EPS Growth (YoY)104.2%-29.2%
FCF Growth (YoY)-76.4%2.34%
Revenue Growth (3Y CAGR)15.8%2.25%
Revenue Growth (5Y CAGR)12.7%6.42%
EPS Growth (3Y CAGR)44.2%-0.17%
EPS Growth (5Y CAGR)12.6%3.77%

Balance sheet

MeasurePhibro Animal HealthIndustry median
Cash & Short-Term Investments$81.99M$62.42M
Net Cash (Debt)$81.99M$15.68M
Net Cash Per Share$2.02$0.66
Equity (Book Value)$385.48M$48.79M
Book Value Per Share$9.49$1.36
Tangible Book Value$295.38M$23.06M
Working Capital$619.04M$75.77M

Financial position

MeasurePhibro Animal HealthIndustry median
Current Ratio2.963.30
Quick Ratio1.012.39
Interest Coverage4.19-7.12

Cash flow (trailing twelve months)

MeasurePhibro Animal HealthIndustry median
Operating Cash Flow$68.95M-$12.35M
Capital Expenditures-$59.09M-$1.06M
Free Cash Flow$9.87M-$20.28M
FCF Per Share$0.24-$0.42

Efficiency

MeasurePhibro Animal HealthIndustry median
Asset Turnover1.060.38
Inventory Turnover2.052.67
Revenue Per Employee$582.76K$398.96K
Profits Per Employee$38.28K-$703.34K
Employee Count2,60574

Dividends and yields

MeasurePhibro Animal HealthIndustry median
Earnings Yield6.24%-22.7%
FCF Yield0.62%-9.07%
Dividend Yield1.22%1.82%
Shareholder Yield1.22%0.00%
Dividend Per Share$0.48$0.83
Dividend Growth (YoY)0.00%2.37%
Years of Dividend Growth00
Payout Ratio19.5%47.7%
FCF Payout Ratio197.3%51.6%

Shares

MeasurePhibro Animal HealthIndustry median
Shares Outstanding40,601,60058,179,650
Shares Change (YoY)0.70%11.1%
Float436,70649,173,100
Shares Held by Insiders98.9%11.6%
Shares Held by Institutions51.8%59.4%

Taxes

MeasurePhibro Animal HealthIndustry median
Income Tax$37.63M$91.50K
Effective Tax Rate27.4%20.6%

Scores

MeasurePhibro Animal HealthIndustry median
Graham Number$22.78$17.36
Graham Upside-42.1%-43.6%
Altman Z-Score3.12-0.24
Piotroski F-Score64
Beneish M-Score-2.18-2.62

Calculated by StockData from Phibro Animal Health's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.